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Brain-derived neurotrophic factor (BDNF) belongs
to the neurotrophin family of neuronal cell survival
and differentiation factors but is thought to be in-
volved in neuronal cell proliferation and myelina-
tion as well. To explore the role of BDNF in vivo, we
employed the intermediate pituitary melanotrope
cells of the amphibian Xenopus laevis as a model
system. These cells mediate background adapta-
tion of the animal by producing high levels of the
prohormone proopiomelanocortin (POMC) when
the animal is black adapted. We used stable X.
transgenesis in combination with the POMC gene
promoter to generate transgenic frogs overex-
pressing BDNF specifically and physiologically in-
ducible in the melanotrope cells. Intriguingly, an
approximately 25-fold overexpression of BDNF re-
sulted in hyperplastic glial cells and myelinated
axons infiltrating the pituitary, whereby the trans-
genic melanotrope cells became located dispersed
among the induced tissue. The infiltrating glial cells
and axons originated from both peripheral and
central nervous system sources. The formation of
the phenotype started around tadpole stage 50 and
was induced by placing white-adapted transgenics
on a black background, i.e. after activation of
transgene expression. The severity of the pheno-
type depended on the level of transgene expres-
sion, because the intermediate pituitaries from
transgenic animals raised on a white background
or from transgenics with only an approximately
5-fold BDNF overexpression were essentially not
affected. In conclusion, we show in a physiological
context that, besides its classical role as neuronal
cell survival and differentiation factor, in vivo BDNF
can also induce glial cell proliferation as well as
axonal outgrowth and myelination. (Molecular En-
docrinology 20: 2987–2998, 2006)
SIMILAR TO ITS neurotrophin family members neu-rotrophin-3 and -4/5, brain-derived neurotrophic
factor (BDNF) was originally identified as a neuronal
survival and differentiation factor. BDNF is now also
known as a modulator of neurotransmission and syn-
aptic plasticity in the central and peripheral nervous
systems (CNS and PNS, respectively) and for its role in
neurite growth (1–11). In addition to these classical
functions, evidence is emerging that BDNF has a
broader role in nervous system functionality. For ex-
ample, BDNF likely functions as a regulator of myeli-
nation in that it enhances myelin formation by
Schwann cells in the PNS (12–14) and by oligoden-
drocytes after spinal cord injury in the CNS (15). In
addition, the neurotrophin may be involved in the pro-
liferation of neuronal cells, because infusion of BDNF
into the lateral ventricle of adult rat led to new neurons
in various brain regions (16), and bacterial meningitis in
mice caused an increase in BDNF expression resulting
in neurogenesis (17). Finally, BDNF may stimulate the
proliferation of glial cells as well (15,18–20). For a
study on the physiological role of BDNF, the melano-
trope cells of the intermediate pituitary of the amphib-
ian Xenopus laevis constitute an attractive cell model
system. BDNF has been found to be expressed in the
Xenopus melanotrope cells (21). The melanotropes
play an essential role in the process of background
adaptation of Xenopus. On a black background, the
melanotrope cells are biosynthetically very active, syn-
thesize large amounts of the prohormone proopiomel-
anocortin (POMC), and release the POMC-derived
peptide -melanophore stimulating hormone (-MSH),
which causes pigment dispersion in skin melano-
phores. In contrast, on a white background the cells
are biosynthetically inactive and -MSH release is in-
hibited. Thus, the biosynthetic and secretory activity of
the melanotrope cells can be physiologically manipu-
lated by placing the animals on either a black or a
white background. At the cellular level, the activity of
First Published Online August 3, 2006
Abbreviations: BDNF, Brain-derived neurotrophic factor;
CNS, central nervous system; GFAP, glial fibrillary acidic
protein; GFP, green fluorescent protein; HE, hematoxylin/
eosin; LFB, Luxol Fast Blue; NIL, neurointermediate lobe;
PNS, peripheral nervous system; POMC, proopiomelanocor-
tin; SP, signal peptide.
Molecular Endocrinology is published monthly by The
Endocrine Society (http://www.endo-society.org), the
foremost professional society serving the endocrine
community.
0888-8809/06/$15.00/0 Molecular Endocrinology 20(11):2987–2998
Printed in U.S.A. Copyright © 2006 by The Endocrine Society
doi: 10.1210/me.2006-0168
2987
the melanotrope cells is regulated by hypothalamic
neurons that directly contact the melanotrope cells
and release various neurochemical messengers (re-
viewed in Refs. 22 and 23).
Previously, effects of BDNF overexpression have
been examined in transgenic mice, in which an in-
crease in myelination (14), dendrite complexity in hip-
pocampal dentate gyrus (24), learning and excitability
(25), and sensory innervation and neuron number (26)
have been observed. In the present study, we com-
bined the unique properties of the Xenopus melano-
trope cell with the technique of stable Xenopus trans-
genesis (27, 28) to explore the role of BDNF in vivo.
Transgene expression of BDNF was driven by a Xe-
nopus POMC promoter fragment, allowing expression
of the transgene to be physiologically inducible and
specific to the melanotrope cells (29), and leaving the
integrity of the regulatory hypothalamic neurons intact.
Analysis of the transgenic animals revealed that in vivo
BDNF can induce Schwann cell and glial cell prolifer-
ation, as well as axonal outgrowth and myelination.
RESULTS
Generation of Transgenic Xenopus with
Overexpression of BDNF Specifically in the
Intermediate Pituitary Melanotrope Cells
To generate frogs transgenic for BDNF, we made and
used two different DNA constructs, one construct driv-
ing transgene expression of BDNF to the melanotrope
cells as well as green fluorescent protein (GFP) to
muscle cells for identification of the transgenics (re-
sulting in transgenic line 6; Fig. 1A), and a second
construct encoding BDNF fused to the C terminus of
GFP (GFP-BDNF) and driving expression to the mela-
notrope cells (transgenic line 73; Fig. 1B). Melanotrope
cell-specific transgene expression was accomplished
by using constructs in which the BDNF- and GFP-
BDNF-encoding sequences were cloned behind a
POMC gene promoter fragment. The transgenic tad-
poles were identified via direct screening for GFP flu-
orescence in muscle (in tadpoles from line 6; Fig. 1A)
or in the intermediate pituitary (in line-73 tadpoles; Fig.
1B).
To examine the amount of steady-state BDNF pro-
tein in the two transgenic lines 6 and 73, lysates of the
pituitary neurointermediate lobe (NIL) and pars distalis
of adult wild-type and transgenic frogs were used for
Western blot analysis with an anti-BDNF antibody.
NILs from transgenic lines 6 and 73 had approximately
5- and 25-fold higher levels of mature BDNF expres-
sion compared with wild-type NILs, respectively (Fig.
2). BDNF transgene expression in lines 6 and 73 was
melanotrope cell specific because the transgene was
not expressed in the pars distalis (Fig. 2). Analysis of
the incubation media showed the secretion of the ma-
ture transgene BDNF-product by line-73 NILs. We did
not detect secreted BDNF from wild-type or line-6
transgenic NILs (Fig. 2, right panel). Because secreted
BDNF is known to have a relatively short half-life (30,
31), the absence of BDNF in the media is probably
caused by protein degradation. We thus generated
transgenic lines 6 and 73 with moderate and relatively
high overexpression of mature BDNF specifically in the
intermediate pituitary melanotrope cells, respectively.
Effect of BDNF Transgene Expression in the
Xenopus Melanotrope Cells on the Anatomy and
Histology of the Pituitary
To examine the effect of BDNF overexpression in the
transgenic melanotrope cells on the histology of the
pituitary, cryo- and paraffin sections were made of
wild-type and lines-6 and -73 pituitaries, and immu-
nocytochemistry screening of the sections was per-
formed using a number of antibodies. Staining with an
anti-POMC/ACTH antibody to identify the melano-
trope cells of the intermediate pituitary and the corti-
Fig. 1. Generation of Transgenic X. laevis with BDNF Overexpression Specifically in Intermediate Pituitary Melanotrope Cells
Schematic representation of the two different constructs that were used to generate transgenic lines 6 (A) and 73 (B).
Transgenic tadpoles were identified via screening for GFP fluorescence in muscle (line 6; A, white arrow) or in the intermediate
pituitary (line 73; B, white arrow). pPOMC, POMC gene promoter; proBDNF, pro-BDNF; pCaC, cardiac actin gene promoter; S,
signal peptide; GFP, enhanced GFP.
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cotropic cells of the pars distalis showed that the
localization of these cells in line-6 transgenic animals
was comparable to that in wild-type animals (Fig. 3, A
and B). Remarkably, in line-73 animals we observed a
nodule that was approximately 10–15 times larger
than the intermediate pituitary of wild-type animals,
and in which the transgenic melanotrope cells were
intermingled in tissue that is normally not found in the
intermediate pituitary (Fig. 3C). Thus, the intermediate
pituitary of line-73 transgenic animals was not intact
anymore. Distributed melanotrope cells were also ob-
served in sections stained with an anti-BDNF antibody
(Fig. 3F) and via direct GFP fluorescence in cryosec-
tions of line-73 transgenic pituitaries (Fig. 3G). The
melanotrope cells of lines-6 and -73 transgenic ani-
mals showed higher expression levels of BDNF than
wild-type cells (Fig. 3, D–F), in line with the Western
blot results (Fig. 2A).
We then wondered what the effect of melanotrope
BDNF overexpression would be on the histology of the
pituitary pars nervosa and pars distalis. Immunocyto-
chemistry screening using an antivasotocin antibody
(specific for vasotocinergic neurons of the pars ner-
vosa) and an antiprolactin antibody (specific for lacto-
tropic cells of the pars distalis) showed that in trans-
genic lines 6 and 73 the two pituitary lobes were
similar to those of wild-type animals (Fig. 3, H–M).
However, occasionally a number of vasotocinergic-
positive fibers were found among the scattered mela-
notrope cells in the nodules of line-73 transgenic an-
imals (Fig. 3J).
To characterize the additional tissue that was ob-
served in the nodules of line-73 transgenic pituitaries,
paraffin sections were stained with hematoxylin and
eosin (HE) and Luxol Fast Blue (LFB) solution (staining
for myelin). We found that in the nodules the melano-
trope cells were surrounded by hyperplastic Schwann
cells and axons of PNS origin and hyperplastic glial
cells and axons of CNS origin. Furthermore, a signifi-
cant part of the various axons was myelinated (Fig.
4A). Additional evidence for the presence of Schwann/
glial cells was provided by immunocytochemistry with
a glial fibrillary acidic protein (GFAP) antibody, show-
ing a clear and specific glial staining in the nodules of
line-73 transgenic pituitaries (Fig. 4B).
Line-6 animals have a relatively low level of trans-
gene BDNF expression in the melanotrope cells. Ini-
Fig. 2. BDNF Protein Expression in the Pituitary NIL of Wild-
Type and BDNF-Transgenic Xenopus
Western blot analysis of NIL and pars distalis (PD) cell
lysates and media of wild-type (wt) and lines-6 and -73 trans-
genic animals using an anti-BDNF antibody. Tubulin expres-
sion served as a loading control.
Fig. 3. Pituitary Histology of Wild-Type Animals and Transgenic Xenopus Overexpressing BDNF in the Intermediate Pituitary
Melanotrope Cells
Serial sagittal paraffin sections were made of the pituitary of wild-type (wt) and lines-6 and -73 transgenic animals, and the
sections were stained for POMC/ACTH (A–C), BDNF (D–F), vasotocin (H–J), and prolactin (K–M). G, Cryosection of the pituitary
of a line-73 transgenic animal showing direct GFP fluorescence. The arrow in J indicates an example of vasotocin-positive fibers
localized in the nodule of a line-73 transgenic pituitary. pn, Pars nervosa; pi, intermediate pituitary; pd, pars distalis; n, nodule.
Scale bars, 200 m (A and B) and 250 m (C).
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tially, we did not detect a pituitary phenotype in these
transgenic animals, and we therefore wondered
whether a relatively long time of adaptation of these
animals to a black background (and thus a relatively
long time period during which cells had been exposed
to the transgene product) may cause a pituitary phe-
notype. For this purpose, line-6 animals were adapted
to a black background for more than 9 months, a
relatively long adaptation period because animals are
normally adapted for 3 wk. Pituitaries of long-term
black-adapted line-6 animals and 3-wk black-adapted
wild-type and line-73 animals were then prepared for
microscopy analysis. Interestingly, in sections of long-
term black-adapted line-6 animals, we detected the
same phenotypic characteristics (namely Schwann
and glial cells and myelinated axons) as were ob-
served in the nodules of line-73 animals (Fig. 5). Thus,
in line-6 transgenic animals a prolonged exposure to
the transgene BDNF product induced a phenotype
similar to that observed in line-73 animals. Further-
more, the fact that two independent BDNF-transgenic
animals (lines 6 and 73) display a similar phenotype
excludes the possibility that the phenotype would be
due to a position effect (i.e. due to the integration of
the transgene).
Together, these results show that the relatively high
transgene BDNF expression in the line-73 pituitaries
resulted in the formation of a nodule that was 10–15
times larger than wild-type intermediate pituitaries. Pi-
tuitaries from line-6 transgenic animals that had been
black adapted for a relatively short time period were
morphologically comparable to wild-type pituitaries,
whereas long-term black adaptation of these animals
resulted in characteristics of the nodule phenotype. In
the nodules of line-73 animals, the melanotrope cells
were intermingled among proliferated Schwann cells
and axons from the PNS, and glial cells and axons of
CNS origin, a significant part of which was myelinated.
Origin of the Nodule in Transgenic Xenopus
Line 73
We then wanted to determine the origin of the induced
tissues in the nodules of line-73 transgenic animals.
The amphibian pituitary is surrounded by a number of
brain areas and cranial nerves that potentially could
form the source of the infiltrating tissues (Fig. 6A).
First, to examine the source of the observed hyper-
plastic Schwann cells and axons, we carefully dis-
Fig. 4. Characterization of Tissues in the Nodules of BDNF-
Transgenic Xenopus Line 73
A, HE and LFB staining for myelin (blue) of sagittal paraffin
sections of the pituitaries of wild-type (wt) and line-73 trans-
genic animals. The upper panels represent overviews of the
whole pituitary, consisting of the pars nervosa (pn), interme-
diate pituitary (pi), and pars distalis (pd). The boxed areas are
enlarged in the lower panels. Scale bars, 200 and 250 m
(upper panels, wt and line 73, respectively) and 25 m (lower
panels). B, GFAP staining of cryosections of the pituitaries of
wt and line-73 transgenic animals. Shown are details of a wt
intermediate pituitary (left panel) and of a line-73 nodule (right
panel). Scale bar, 25 m.
Fig. 5. Light-Microscopical Pictures of 1-m Epon Sections of the Pituitaries of Relatively Long-Term Black-Adapted (BA) Line-6
Transgenic Xenopus and 3-wk BA Wild-Type (wt) and Line-73 Transgenic Animals
Shown are details of the intermediate pituitaries of wild-type Xenopus and lines-6 and -73 transgenic Xenopus. c, Melanotrope
cell; a, myelinated axon; g, Schwann/glial cell. Scale bar, 10 m.
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sected the brain and pituitary of wild-type, line-6, and
line-73 animals under a stereomicroscope (Fig. 6,
B–E). In line-6 transgenic animals that were adapted to
a black background for 3 wk (a relatively short period
of adaptation), the morphology of the NILs was com-
parable to that of wild-type NILs (Fig. 6, B and C). In
contrast, the nodule-containing pituitaries of line-73
transgenic animals were anatomically connected to
two cranial nerves, i.e. cranial nerves V and VII (the
trigeminal and facial nerves, respectively; Fig. 6, A and
E). In addition, in transgenic line-6 animals that were
adapted to a black background for 9 months (a rela-
tively long adaptation period) the NILs were also con-
nected to these cranial nerves (Fig. 6D). Thus, because
the nodules in line-73 transgenic pituitaries were an-
atomically connected to the facial and trigeminal
nerves, the infiltrating PNS-derived Schwann cells and
myelinated axons that were present in the nodules
probably originated from these cranial nerves.
We next examined in more detail from which CNS
region the hyperplastic glial cells and axons in the
line-73 nodules originated. Staining of paraffin sec-
tions of line-73 pituitaries with an antimesotocin or
antivasotocin antibody revealed in the nodule the
presence of mesotocinergic and vasotocinergic fibers
from the pituitary pars nervosa (Fig. 6, F and G). These
results indicated that the glial cells and axons with
CNS characteristics found in the nodules of line-73
Fig. 6. Origins of the Hyperplastic Schwann Cells, Glial Cells, and Axons in the Nodules of BDNF-Transgenic Xenopus Line 73
A, Schematic lateral view of a frog brain. Schematic was derived from Nieuwenhuys et al. (49). VIIIa, Nervus vestibulocochlearis,
posterior root; VIIIb, nervus vestibulocochlearis, anterior root; VII, nervus facialis; V, nervus trigeminus; III, nervus oculomotorius;
pn, pars nervosa; pi, intermediate pituitary; pd, pars distalis. B–E, Dorsal view of the brain cavity (c) after removal of the brain (br)
of a wild-type (wt) animal (B), transgenic line-6 animals [short- and long-term black-adapted (BA); C and D, respectively] and
transgenic line-73 animal (E). The pituitary pars distalis (pd) and neurointermediate lobe (NIL) are visible lying on the floor of the
brain cavity. The numbers V/VII indicate the trigeminal and facial nerves, and the white arrowheads indicate connections between
these nerves and the NIL (line 6) or nodule (line 73). Scale bar, 1 mm. F and G, Sagittal paraffin sections of a line-73 pituitary
stained with antimesotocin (F) or antivasotocin (G) antibody. Examples of mesotocinergic- or vasotocineric-positive fibers in the
intermediate pituitary are indicated with arrows. Scale bar, 200 m.
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pituitaries most likely originated from the pituitary pars
nervosa.
Altogether, our study concerning the origin of the
PNS-derived hyperplastic Schwann cells and axons,
and CNS-derived glial cells and axons, in the nodules
of line-73 transgenic animals indicated that the PNS-
and CNS-derived infiltrating tissues originated from
the cranial nerves V and VII, and the pituitary pars
nervosa, respectively.
Development of the Nodule in Transgenic
Xenopus Line 73
We were also interested at what time during develop-
ment of the line-73 transgenic animals the pituitary
nodule appeared. For this reason, at a number of
developmental stages black-adapted wild-type and
line-73 tadpoles were fixed for paraffin sectioning and
staining (HE and myelin) and immunocytochemistry for
POMC and BDNF. Up to stage 49 (12 d after fertili-
zation), no differences were found between the devel-
oping pituitaries of wild-type and transgenic tadpoles
(Fig. 7A and data not shown). In contrast, in stage
50–51 tadpoles (15–17 d after fertilization) we found
that the line-73 intermediate pituitary was slightly dis-
rupted by infiltrating tissue (Fig. 7B and data not
shown). This phenotype progressively further devel-
oped (Fig. 7C and data not shown) and, after meta-
morphosis (stage 66; 50 d after fertilization), clearly
enlarged nodules were present in the pituitaries of
line-73 frogs, with the melanotrope cells intermingled
throughout glial cells (Fig. 7D and data not shown).
Thus, the phenotype in line-73 transgenic animals was
observed for the first time in stage 50–51 tadpoles and
became gradually more pronounced during further de-
velopment of the transgenic animal.
Physiological Induction of the Nodule in
Transgenic Xenopus Line 73
Next, we wondered whether increasing the level of
BDNF transgene expression in the melanotrope cells
of tadpoles and frogs with a low level of transgene
expression would induce the formation of the nodule.
For this purpose, we took advantage of our model
system by first growing line-73 transgenic tadpoles on
a white background, giving low expression of the
BDNF transgene. After metamorphosis, paraffin sec-
Fig. 7. Development of the Nodule Phenotype in BDNF-Transgenic Xenopus Line 73
At various developmental stages [stage 49 (A), stage 50–51 (B), stage 56 (C) and immediately after metamorphosis (D)]
wild-type (wt) and transgenic line-73 tadpoles were fixed for serial paraffin sectioning and immunocytochemistry for POMC/ACTH
and BDNF. The locations of the intermediate pituitary (pi), pars distalis (pd), and pars nervosa (pn) are indicated. The dotted arrows
in B indicate displaced intermediate pituitary melanotrope cells in line 73 transgenic animals. Scale bars, 50 m (A–C) and 200
m (D).
2992 Mol Endocrinol, November 2006, 20(11):2987–2998 de Groot et al. • BDNF Induces Glial Cell Proliferation
tions were made of the brain and pituitary, and immu-
nocytochemistry for POMC and BDNF, and HE and
myelin stainings were also performed. We found that
pituitaries of white-adapted transgenic frogs did not
contain nodules and were similar to wild-type pituitar-
ies from animals adapted to a white background (Fig.
8). We then performed a longitudinal study by adapt-
ing fully white-adapted line-73 transgenic frogs to a
black background for various time periods, thus in-
creasing transgene BDNF expression in a physiologi-
cal way. Western blot analysis indeed showed that
transgene BDNF expression was approximately 8-fold
higher in black- compared with white-adapted line-73
animals (data not shown). After 9 wk of black-back-
ground adaptation, infiltrating glial cells were observed
that displaced the intermediate pituitary melanotrope
cells of the transgenic animals. After 15 wk of adap-
tation, a nodule was formed with the melanotrope cells
intermingled throughout the glial cells (Fig. 9). When
the 15-wk black-adapted line-73 animals were placed
back on a white background again, the induced nod-
ule remained (data not shown). Thus, the nodule phe-
notype of the transgenic Xenopus line-73 pituitary was
irreversibly induced by enhancing BDNF transgene
expression.
DISCUSSION
BDNF is a well-known neurotrophic growth factor that
plays an important role in neuronal cell survival, differ-
entiation, growth, and synaptic plasticity (e.g. re-
viewed in Refs. 1–5 and 11). However, BDNF appears
to have more physiological functions than previously
thought, e.g. it has been implicated also in the forma-
tion of myelin in the central and peripheral nervous
systems (12–15, 32, 33), and may play a role in the
proliferation of neuronal cells (16, 17). We have exam-
ined functional aspects of BDNF using the Xenopus
intermediate pituitary melanotrope cells as a model
system. The melanotrope cells regulate the process of
background adaptation of the frog via the production
and release of the pigment-dispersing hormone
-MSH by the biosynthetically highly active cells when
the animals are on a black background, whereas on a
white background the cells are inhibited and biosyn-
thetically inactive (reviewed in Refs. 22 and 23).
In this study, we generated via stable Xenopus
transgenesis frogs with overexpression of BDNF spe-
cifically in the intermediate pituitary melanotrope cells.
Two independent transgenic lines were created, one
with a relatively low (5-fold; transgenic line 6) and a
second with a high (25-fold; transgenic line 73) level
of transgene expression of mature BDNF. Intriguingly,
in line-73 transgenic animals with high levels of BDNF
transgene expression we found infiltrating hyperplas-
tic Schwann cells, glial cells, and axons that intermin-
gled with the melanotrope cells of the intermediate
pituitary, resulting in a nodule with a size 10–15 times
larger than a wild-type intermediate pituitary. This phe-
notype was a specific effect of transgene expression
of mature BDNF and not of other transgene products
(e.g. GFP or the prodomain of BDNF), because we
detected characteristics of the nodule phenotype in
line-6 transgenic animals expressing untagged
proBDNF and generated other transgenic lines ex-
pressing GFP alone or noncleavable GFP-proBDNF
that did not show the pituitary phenotype (data not
shown). In wild-type Xenopus intermediate pituitaries,
only a limited number of GFAP folliculo-stellate cells
have been found (34, 35). To estimate the increase in
Schwann and glial cells in the line-73 nodules, GFAP
cells per unit area were counted, revealing an approx-
imately 18-fold increase in GFAP cells in line-73
nodules compared with wild-type intermediate pitu-
itaries (data not shown). A proliferative effect of BDNF
on glial cells has thus far been described only in a
limited number of studies; e.g. BDNF increased the
cell number of two microglial cell lines (19), [3H]-thy-
midine incorporation in microglia cells (20), the cell
number of optic nerve head astrocytes (18), and oli-
godendrocyte proliferation in the contused adult rat
spinal cord (15). We show now that in vivo BDNF
stimulates the proliferation of both glial cells and
Schwann cells, providing evidence that the neurotro-
phin may regulate glial cell functioning in the nervous
system. Furthermore, the presence of many axons in
the nodules of line-73 transgenic animals suggests
that BDNF also stimulates axonal outgrowth.
Upon closer examination of the origin of the infiltrat-
ing tissues in the nodules of line-73 pituitaries, we
observed both CNS-derived glial cells and axons and
PNS-derived Schwann cells and axons. The mesoto-
cin- and vasotocin-stained paraffin sections of the
nodules and the HE-stained sections of the early
Fig. 8. Pituitary Histology of White-Adapted Wild-Type Xe-
nopus and Transgenic Xenopus Line 73
Serial paraffin sections were made of the brain and pitu-
itary [consisting of the pars nervosa (pn), intermediate pitu-
itary (pi), and pars distalis (pd)] of wild-type (wt) and trans-
genic line-73 frogs that were raised on a white background
(WA). Stainings were performed for POMC/ACTH and BDNF.
Scale bar, 200 m.
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stages of nodule formation in line-73 transgenic ani-
mals showed that the glial cells and axons with CNS
characteristics most likely originated from the pituitary
pars nervosa. The main glial cells that are present in
the wild-type pituitary pars nervosa form a specialized
group of glial cells, called pituicytes (36–40), and it is
therefore possible that in our line-73 transgenic ani-
mals BDNF stimulated the proliferation of the pi-
tuicytes. Because the nodules were anatomically
tightly connected to the cranial nerves V and VII (the
trigeminal and facial nerves, respectively), the PNS-
derived Schwann cells and axons most likely origi-
nated from these cranial nerves. The question then
arose why only the cranial nerves V and VII and not
other also nearby-situated cranial nerves, such as cra-
nial nerve III, were affected by the overexpression of
BDNF in the transgenic melanotrope cells. We there-
fore considered the possibility that the BNDF recep-
tors TrkB or p75NTR may be differentially expressed in
various cranial nerves. Quantitative RT-PCR analysis
of TrkB and p75NTR mRNA expression showed no
significant differences in the mRNA levels of these
receptors between cranial nerves III, V, and VII of
wild-type animals (data not shown), indicating that the
TrkB and p75NTR receptors are probably not respon-
sible for the effect of the BDNF transgene product
specifically on cranial nerves V and VII. A more likely
explanation for the specific induction of the observed
phenotype may well be the fact that cranial nerves V
and VII are localized in close proximity of the pituitary,
making them prime targets for the BDNF protein that
was overexpressed in the intermediate pituitary mela-
notrope cells.
A large portion of the infiltrated axons of the line-73
nodules was myelinated, indicating that overexpres-
sion of BDNF may stimulate myelin formation. Neuro-
nal BDNF has previously been shown to stimulate the
expression of myelin protein by Schwann cells (41),
presumably via its interaction with p75NTR (12–15, 32,
33). In the induced nodule of line-73 animals, the PNS-
derived Schwann cells and axons appeared more sen-
sitive to the myelinating effect of BDNF than the CNS-
derived glial cells and axons from the pars nervosa,
possibly because PNS tissue was found to contain
higher p75NTR mRNA expression levels than CNS tis-
sue (data not shown).
Our longitudinal study on the development of the
nodule phenotype in line-73 transgenic animals re-
vealed in tadpoles of stage 50/51 the first cells infil-
trating the intermediate pituitary. In X. laevis, endoge-
nous MSH-containing intermediate pituitary cells are
found in tadpoles from stage 35/36 onward (42), and
melanotrope cell-specific GFP transgene expression
driven by the POMC transgene promoter has been
detected from stage 40 onward (29). Thus, in line-73
embryos the transgene expression of BDNF from
stage 40 onward apparently resulted in a detectable
phenotype in transgenic embryos of stage 50/51, fol-
lowed by a gradual formation of the nodule during
further development of the transgenic animals.
A number of observations suggest that the severity
of the nodule phenotype of the transgenic frogs was
Fig. 9. In vivo Induction of Nodule Formation in Transgenic Xenopus Line-73 Pituitaries by the Physiological Activation of BDNF
Transgene Expression
Wild-type (wt) and transgenic line-73 animals grown on a white background were adapted to a black background for 4, 9, or
15 wk (Wks BA). After fixation and serial paraffin sectioning of the pituitary [consisting of the pars nervosa (pn), intermediate
pituitary (pi) and pars distalis (pd)], immunocytochemistry was performed for POMC/ACTH and BDNF. Of 9 wk BA line-73 animals,
two sections are shown for the POMC/ACTH as well as the BDNF staining, with the lower panel showing a higher magnification
of part of the pi and pn. Black and dotted arrows indicate infiltrating tissue and displaced melanotrope cells, respectively. Scale
bar, 200 m.
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dependent on the level of BDNF transgene expression.
First, initially line-6 transgenic animals with an approx-
imately 5-fold overexpression of BDNF did not show
nodule formation, but the phenotype was induced fol-
lowing a long adaptation of the animal to a black
background, i.e. after extensive exposure of the tissue
surrounding the intermediate pituitary cells to the
transgene product. Second, the intermediate pituitary
of line-73 transgenic frogs that were continuously
grown on a white background did not show abnormal-
ities, whereas black-background-adapted line-73
frogs had a clearly affected intermediate pituitary.
Third, when white-adapted, nonaffected line-73 frogs
were adapted to a black background for several
weeks, hyperplastic glial cells infiltrating the interme-
diate pituitary were observed, eventually leading to the
nodule. The formation of the nodule was irreversible,
because the phenotype of black animals remained
when the animals were placed on a white background.
Altogether, the results of our transgenic studies in a
physiological context show that, besides its classical
role as neuronal survival and differentiation factor, in
vivo BDNF can induce axonal outgrowth and myelina-
tion and stimulate glial cell proliferation.
MATERIALS AND METHODS
Animals
South African claw-toed frogs, X. laevis, were reared in green
containers (unless stated otherwise) in the Central Animal
Facility of the Radboud University of Nijmegen (Nijmegen,
The Netherlands), with a light/dark cycle of 12 h. The animals
were adapted to their background by keeping them in either
white or black buckets for at least 3 wk. For long-term black
adaptation, line-6 transgenic animals were kept on a black
background for more than 9 months. Experimental proce-
dures were performed under the guidelines of the Dutch law
concerning animal welfare.
Antibodies
Pro- and mature BDNF were detected with an anti-BDNF
antibody directed against the first 20 amino acids of mature
BDNF (Santa Cruz Biotechnology, Inc., Santa Cruz, CA).
POMC and ACTH were detected with an anti-POMC/ACTH
antibody (generous gift of Dr. E. Roubos, Radboud Univer-
sity, Nijmegen, The Netherlands; Ref. 43), vasotocin and me-
sotocin with an antivasotocin and antimesotocin antibody,
respectively (generous gifts of Dr. F. Vandesande and Dr. L.
Arckens, respectively, Catholic University Leuven, Belgium;
Refs. 44 and 45), and prolactin with an antiprolactin antibody
(generous gift of Dr. J. Mattheij, Wageningen University, The
Netherlands; Ref. 46). GFAP was detected with a polyclonal
anti-GFAP antibody (DAKO, Glostrup, Denmark), and tubulin
was detected with the monoclonal E7 anti-tubulin antibody
(Developmental Studies Hybridoma Bank, Rockland,
Gilbertsville).
Generation of DNA Constructs Encoding BDNF
Two different constructs encoding BDNF [pPCG(A)-BDNF]
and a GFP-BDNF fusion protein [pPOMC(A)-SP-GFP-
BDNF] were generated. For the construction of pPCG(A)-
BDNF, first the pPCG(A)2 vector was made, consisting of
the pCS2 backbone (47), a 540-bp SalI-HindIII Xenopus
POMC gene A promoter sequence (29), a 0.65-kb SalI-HindIII
fragment of the cardiac actin promoter (kindly provided by
Paul Krieg, Department of Cell Biology and Anatomy, Univer-
sity of Arizona Health Sciences Center, Tucson, AZ), the GFP
sequence, and the HSV-tk polyA signal obtained by PCR on
the pIRES2-EGFP vector (Clontech, Mountain View, CA). To
clone the BDNF sequence, total RNA was isolated from rat
brain tissue according to the manufacturer’s instructions (Life
Technologies, Inc., Carlsbad, CA). The RNA was dissolved in
20 l ribonuclease-free H2O, and the concentration was mea-
sured with a GeneQuant RNA/DNA calculator (Pharmacia,
New York, NY). For RT-PCR, one g total rat brain RNA was
reverse transcribed into cDNA according to the manufacturer’s
instructions (Life Technologies, Inc.). BDNF was amplified by
PCR in a reaction mixture containing Pfu buffer (Fermentas,
Hanover, MD), 200 M deoxynucleoside triphosphates, 0.5 mM
5 primer (5-ggggaagcttgttccaccaggtgagaagagtgatg-3), 0.5
mM 3 primer (5-gggggaattctgcgcaaatgactgtttctttctggtc-3),
0.01 U Pfu Turbo DNA polymerase (Fermentas), and 1 l cDNA
(35 amplification cycles: 30 sec at 95 C, 1 min at 56 C, and 1.5
min at 72 C). The amplified product was digested with HindIII
and EcoRI and cloned behind the POMC gene A promoter
fragment in the vector pPCG(A)2, resulting in the pPCG(A)-
BDNF vector. Because the rat and X. laevis protein sequences
of mature BDNF are highly conserved (amino acid sequence
identity is 94%) and, in view of the pituitary nodule phenotype of
the BDNF-transgenic animals, the transgene mature BDNF
product was likely recognized by the frog receptors. For the
construction of the pPOMC(A)2-SP-GFP vector, the coding
sequence of GFP was amplified via PCR and fused in the
correct reading frame downstream of the signal peptide (SP)
sequence of Xenopus Ac45. The SP-GFP fusion was subcloned
with BamHI and EcoRI into the pCS2(A) vector, thereby gen-
erating pCS2(A) SP-GFP. Finally, the cytomegalovirus pro-
moter was interchangedwith the POMCpromoter (29) using the
SalI and HindIII restriction sites. Next, to generate the GFP-
BDNF fusion protein, the sequence of BDNF without the signal
peptide was amplified via PCR (35 amplification cycles; 30 sec
95 C, 1 min 50 C and 1.5 min 72 C), using 10 ng pPCG(A)-
BDNF vector as input DNA, and the primers 5-gggggaat-
tcgcgcccactgaaagaagcaaacg-3 and 5- ggggtctagagcgcaaat-
gactgtttc-3. The amplified product was digested with EcoRI
andXbaI and cloned in frame behind the sequence of GFP in the
pPOMC(A)2-SP-GFP vector. This resulted in the
pPOMC(A)-SP-GFP-BDNF vector. The generated constructs
were checked by cycle sequencing using the Big Dye Ready
Reaction system (PerkinElmer, Wellesley, MA).
Generation of Xenopus Transgenic for BDNF
To generate transgenic frogs, linear 3577-bp and 2546-bp
SalI/NotI DNA fragments were generated from the
pPCG(A)2-BDNF and pPOMC(A)2-SP-GFP-BDNF con-
structs, respectively. These linear fragments were used for
stable Xenopus transgenesis (27, 28). A number of injection
rounds resulted in animals transgenic for BDNF (line 6) and
the fusion protein GFP-BDNF (line 73). To generate F1 and F2
offspring, the testes of male transgenic Xenopus frogs were
isolated and used for in vitro fertilization of eggs harvested
from wild-type Xenopus females.
Western Blot Analysis
To analyze protein expression in wild-type and transgenic
pituitary NILs (consisting of the pars nervosa and intermedi-
ate pituitary) and pars distalis, tissue homogenates were
made in lysis buffer (50 mM HEPES, 140 mM NaCl, 0.1%
Triton X-100, 1% Tween 20, 1 mM EDTA, 1 mg/ml deoxy-
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cholate, 1 M phenylmethylsulfonyl fluoride, 0.1 mg/ml soy-
bean tryspin inhibitor). To analyze secreted proteins by NILs,
lobes were incubated in Ringer’s medium [112 mM NaCl, 15
mM HEPES (pH 7.4), 2 mM KCl, 2 mM CaCl2, 2 mg/ml glucose,
and 0.3 mg/ml BSA] for 3 h, after which media were collected
and NILs were homogenized. After a 20-min incubation on
ice, samples were centrifuged for 20 min (15,300 rpm, 4 C)
and sample buffer (50 mM TrisCl (pH 6.8), 100 mM dithiothre-
itol, 2% sodium dodecyl sulfate, 0.1% bromephenol blue,
10% glycerol) was added to the supernatant. Samples were
heated for 5 min at 100 C, and Western blot analysis was
performed as described previously (48). Blots were incubated
overnight with primary antiserum, and the antibody dilutions
used were 1:1000 for anti-BDNF and 1:500 for antitubulin.
The equivalent of approximately 40% of one NIL or pars
distalis was loaded per lane. Signals were visualized with a
BioChemi Imaging System, and relative quantification by
densitometry was performed with Labworks 4.0 software
(UVP BioImaging Systems, Cambridge, UK). Densities of ma-
ture BDNF signals in NILs of wild-type, line-6, and line-73
transgenic animals and of white- and black-adapted line-73
animals were measured and related to an approximately 47-
kDa nonspecific immunoreactive signal as an internal control
or to tubulin expression, respectively. An unpaired t test was
used for statistical analysis.
Immunocytochemistry
For cryosectioning, Xenopus brains with pituitary glands at-
tached were immersed in 10% sucrose in 0.1 M sodium
phosphate buffer (pH 7.4) for 16 h at 4 C and subsequently
frozen in Tissue-Tek (Sakura, Tokyo, Japan). Sagittal sections
(20 m) were mounted on poly-L-lysine-coated slides and
dried at 37 C for 16 h. Finally, direct GFP fluorescence was
viewed under a fluorescence microscope. Alternatively, Xe-
nopus brains with pituitary glands attached were frozen in
liquid N2 immediately after dissection. Next, sagittal sections
(5 m) were mounted on uncoated slides and dried at room
temperature for 12 h. For immunocytochemistry, sections
were blocked in 0.2% BSA in PBS for 30 min and subse-
quently incubated with primary antiserum (1:100 anti-GFAP)
for 1 h and secondary antiserum (1:200 goat antirabbit Alexa
488) for 1 h.
For paraffin sectioning, Xenopus brains with pituitary
glands attached were fixed for 4–12 h in Bouin-Hollande
solution, dehydrated, and embedded in paraffin. Serial sag-
ittal 5-m sections were mounted on gelatin-coated glass
slides. After deparaffinization and rehydration, sections were
blocked with 20% normal goat serum in Tris-buffered saline
for 10 min and then incubated with primary antiserum (1:300
anti-BDNF, 1:2000 anti-POMC/ACTH, 1:4000 antivasotocin
and antimesotocin, and 1:500 antiprolactin) for 16 h, with
goat antirabbit IgG (1:100; Nordic Immunology, Tilburg, The
Netherlands) for 1 h, and finally with rabbit peroxidase-anti-
peroxidase (1:800; Nordic Immunology) for 1 h. To detect
BDNF, sections were incubated with anti-BDNF antibody for
24 h, subsequently with biotinylated goat antirabbit Ig (1:200;
Vectastain; Vector Laboratories, Burlingame, CA) for 2 h, and
finally with ABC reagent (1:100; Vectastain) for 30 min. Fi-
nally, after antibody incubations and washing in TBS without
saline, sections were treated with 0.025% 3,3-diaminoben-
zidine tetrahydrochloride (Sigma), 0.25% nickel ammonium
sulfate, and 0.01% hydrogen peroxide in 0.05 M Tris-HCl (pH
7.6) to reveal peroxidase activity. For myelin staining, paraf-
fin-embedded sections were incubated in LFB solution (0.1%
LFBMBS, Chroma, Muenster, Germany; 0.05% acetic acid in
96% ethanol) for 16 h, followed by a differentiation of 1 min
in 0.1% lithium carbonate and 3–5 min in 70% ethanol. Fi-
nally, the sections were stained with HE.
Microscopy Analysis
For microscopy analysis of Xenopuswild-type and transgenic
pituitaries, paraffin sections of the tissues were examined in
a Leitz Dialux 22 microscope (Leica Microsystems, Wetzlar,
Germany), and photographs were taken with a Nikon Coolpix
900 camera (Nikon, Tokyo, Japan). Cryosections were di-
rectly viewed under a Leica DM RA fluorescence microscope,
and photographs were taken with a Cohu High Performance
CCD Camera (Cohu, Inc., San Diego, CA) using the Leica Q
Fluoro software. Dissection of Xenopus brain and pituitary
was performed under a Leica MZ FLIII fluorescent stereomi-
croscope, and photographs were taken with a Leica DC200
color camera using the Leica DCviewer software. For a more
detailed microscopy analysis of Xenopus wild-type and
transgenic pituitaries, freshly dissected NILs of long-term
black-adapted line-6 animals and 3-wk black-adapted wild-
type and line-73 Xenopus were used. Whole lobes were fixed
by high-pressure freezing (Leitz) and substituted by auto-
matic freeze substitution using acetone and 2% osmium
tetroxide. Next, tissues were rinsed with acetone, incubated
in epon:acetate, and embedded in Epon 812. One-microme-
ter-thick sections were cut and stained with toluidine blue.
Subsequently, the sections were examined under a Leica
DM6000Bmicroscope, and pictures were taken using a Leica
DFC480 camera and Leica IM500 Image manager software.
Quantification of GFAP Cells
To estimate the number of GFAP cells in GFAP-stained
cryosections of the pituitaries of wild-type and line-73 trans-
genic animals, the number of GFAP cells was counted in six
(wild-type) and nine (line 73) unit areas (80  80 m) in two
different sections of the intermediate pituitary and nodule of
wild-type and line-73 animals, respectively. Because in
line-73 animals the GFAP cells were not evenly distributed
throughout the nodule, unit areas mainly consisting of glial
cells were chosen. Cell counts were summed for each animal
and the mean for line-73 animals was compared with those of
wild-type animals. An unpaired t test was used for statistical
analysis.
Real-Time Quantitative RT-PCR Analysis
To examine TrkB and p75NTR neurotrophin receptor mRNA
expression levels in the NIL and cranial nerves III, V, and VII,
real-time quantitative RT-PCR analysis was performed as
described previously (48), using the iTaq SYBR Green Su-
permix with ROX kit (Bio-Rad, Hercules, CA). The following
primer sets were used to amplify TrkB, p75NTR, and glycer-
aldehydes-3-phosphate dehydrogenase (GAPDH), respec-
tively: 5-acctctaccgcgagcaagac-3 and 5- gagtaactctgcttc-
ccgatgaa-3 (forward and reverse primer for TrkB,
respectively), 5-gggaaagtctgagcttgctg-3and 5-cactatctgt-
gaggacggtg-3 (forward and reverse primer for p75NTR, re-
spectively) and 5-gccgtgtatgtggtggaatct-3 and 5-aagtt-
gtcgttgatgacctttgc-3 (forward and reverse primer for
glyceraldehydes-3-phosphate dehydrogenase, respectively).
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